They gave him 3,000 units of tetanus immune globulin, the diphtheria, tetanus, and acellular pertussis vaccine (DTaP), and antibiotics. A six-year-old on a mechanical ventilator is not a pleasant ...

Human Acellular Vessel (HAV). The U.S. regulator accepted Humacyte’s (HUMA) biologics license application for HAV early this ...

Surge in whooping cough cases seen in US and Europe, particularly affecting infants. Experts warn of potential tenfold ...

Humacyte's stock price has recently been on an impressive bull run. Read why I could see HUMA achieving a billion-dollar ...

Several randomized pertussis vaccine efficacy studies were conducted in Europe and Africa to compare the safety and efficacy of the acellular and the whole-cell pertussis vaccines for the ...

Can an acellular slime mold mimic the Roman road network in the Balkans? It’s not a riddle, but the subject of a new study by researchers in Greece and the United Kingdom. That slime mold ...

The Department of Public Health and Social Services is advising travelers to stay up to date with their vaccinations as ...

The global breast reconstruction surgery and treatment market is anticipated to amass a revenue of USD 1.61 billion in 2033, rising from an estimated USD 901.3 million in 2023. The market is set to ...

Financial Outlook: Expects current cash reserves to fund operations for at least 12 months, aligning with anticipated timelines for FDA approval of HAV in vascular trauma.

Overall, the vaccine recommendations vary considerably with different primary and booster schedules, with the use of either whole-cell or acellular vaccines with different vaccine formulations ...